GJB2
Connexin 26: GJB2 Targeted Analysis
Key Information
Lab:
TAT:
14 days
Price:
$350
CPT Code(s):
81253
Test Code:
DGJT
Prenatal Samples Accepted
Connexin 26: GJB2 Targeted Analysis
Connexin 26 targeted analysis is a molecular test used to detect a specific variant previously identified in the GJB2 gene. Targeted analysis can be used for known familial testing.
Non-syndromal autosomal recessive hearing loss
Clinical Information
The frequency of childhood deafness is estimated to be 1/500. Half of this hearing loss is genetic and approximately 80% of genetic hearing loss is nonsyndromic and inherited in an autosomal recessive manner. Approximately 50% of childhood nonsyndromic recessive hearing loss is caused by variants in the connexin 26 (Cx26) gene, GJB2, making it the most common form of autosomal recessive nonsyndromic hearing loss with a carrier rate estimated to be as high as 1 in 36 (2.8%). Newborns with confirmed hearing loss should have Cx26 testing. Cx26 testing will help define a group in which approximately 60% will have profound or severe-profound hearing loss requiring aggressive language intervention.
Technical Information
Specimen Requirements
Transport Instructions
Prenatal Testing Information
Prenatal diagnosis may be available for familial pathogenic or likely pathogenic variants; full sequencing of the GJB2 gene is not available. For variants identified at external laboratories, GGC will need to review the variant classification prior to sample receipt. Prenatal diagnosis is not available for variants of uncertain clinical significance. Additional fees for cell culture and maternal cell contamination may apply. Maternal cell contamination studies are required for all prenatal molecular tests. Contact the laboratory prior to sending a prenatal specimen to confirm that targeted testing can be accepted.
Prenatal Specimen Requirements
Prenatal Transport Instructions
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
